| Report ID | 266202 |
| Drug Identification Number | 00608165 |
| Brand name | TEVA-OXYCOCET |
| Common or Proper name | OXYCOCET TABS 5MG/325MG (CS) |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETAMINOPHEN OXYCODONE HYDROCHLORIDE |
| Strength(s) | 325MG 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | N02AJ |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-08-27 |
| Estimated end date | 2026-02-10 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-01-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v26 | 2026-01-15 | French | Compare |
| v25 | 2026-01-15 | English | Compare |
| v24 | 2026-01-08 | French | Compare |
| v23 | 2026-01-08 | English | Compare |
| v22 | 2025-12-04 | French | Compare |
| v21 | 2025-12-04 | English | Compare |
| v20 | 2025-11-27 | French | Compare |
| v19 | 2025-11-27 | English | Compare |
| v18 | 2025-11-13 | French | Compare |
| v17 | 2025-11-13 | English | Compare |
| v16 | 2025-11-06 | French | Compare |
| v15 | 2025-11-06 | English | Compare |
| v14 | 2025-11-05 | French | Compare |
| v13 | 2025-11-05 | English | Compare |
| v12 | 2025-10-02 | French | Compare |
| v11 | 2025-10-02 | English | Compare |
| v10 | 2025-09-25 | French | Compare |
| v9 | 2025-09-25 | English | Compare |
| v8 | 2025-09-12 | French | Compare |
| v7 | 2025-09-12 | English | Compare |